Shelley Wood is a former Editor-in-Chief at TCTMD. Throughout her career, she has focused on interventional cardiology and medical journalism, earning numerous awards for her work and the publications she has led. Shelley’s contributions have been featured in The Globe and Mail, TCTMD, Medscape, and STAT News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
Shelley Wood's focus is on medical research, particularly in the field of cardiology and heart disease. Her coverage attributes suggest a strong reliance on data-driven content.
To effectively reach out to Shelley, consider providing pitches that highlight new and significant findings from medical research or clinical trials within the field of cardiology. Emphasize insights that are supported by robust data and offer potential advancements in pharmaceutical treatments for heart-related conditions.
Given her strong emphasis on citing data, ensure that any information provided is backed by reliable sources and studies. It may also be beneficial to provide access to experts who can interpret complex scientific findings related to cardiology in a clear and accessible manner.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Shelley Wood, Eric J. Topol
Skepticism, business imperatives, and changing demographics are muddying the clear-blue waters By Shelley Wood and Eric J. Topol
